1.
Vynnychenko O, Moskalenko Y. INFLAMMATORY MARKERS AS PREDICTORS OF EFFICACY OF BEVACIZUMAB AND TYROSINE KINASE INHIBITORS THERAPY IN METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS. East. Ukr. Med. J. [Internet]. 2024Dec.29 [cited 2026Jul.4];12(4):1007-1. Available from: https://eumj.med.sumdu.edu.ua/index.php/journal/article/view/718